CrossMab Products
-
- Targets: CD30 & ErbB2
- Type: CrossMab
- Application: ELISA
Compare
-
- Targets: PAC1 receptor & CGRP receptor
- Type: CrossMab
- Application: ELISA
Compare
-
- Targets: ROR1 & CD3
- Type: CrossMab
- Application: FC
Compare
-
- Targets: MCSP & CD3
- Type: CrossMab
- Application: FC, ELISA
Compare
-
- Targets: EGFR & Fcgr1
- Type: CrossMab
Compare
-
- Targets: CEA & HSG
- Type: CrossMab
Compare
-
- Targets: Ang2 & VEGFA
- Type: CrossMab
Compare
-
- Targets: HRPO & biotin
- Type: CrossMab
- Application: FuncS, Immunoassay
Compare
-
- Targets: EGFR & doxorubicin
- Type: CrossMab
- Application: FuncS, Pretargeting system for therapic agent delivery
Compare
-
- Targets: Tweak & IL17
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PLAP & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CR1/2 & ΦX174
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGFA & VEGFA
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Kit & VCAM-1
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Fibrin & PLAU
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: TFRC & gp40
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PLAT & Fibrin
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRI & EGF
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: S. pneumoniae & FcαR
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CC531 & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CC531 & CD8
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD59 & CD38
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRI & CD33
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: SLA & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL2RA & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: HN & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: HER2 & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD20 & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD19 & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD20 & CD22
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD59 & CD19
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CGA & CGB
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGFR2 & VEGFR2
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: HLA-A & CD55
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: G250 & CD55
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL17 & TNF
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: BCMA & TACI
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD8 & IL2
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD4 & IL2
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & HER3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: HER2 & HER2
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FIXa & FX
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRI & DENV
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD33 & DENV
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD15 & DENV
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: GLUT2 & CTLA-4
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRIII & CD30
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: MET & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CXCR5 & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Ovarian cancer & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CLEC12A & CD3
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & FcγRIII
- Type: CrossMab
- Application: FuncS, Promising therapeutic agent
Compare
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.